Revenue
attach_money23M USD
-
SPRYARS Pharmaceuticals, Inc.$ --
ARS Pharmaceuticals, Inc.
SPRY
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2026 Q1Updated: 03/31/2026
Operating Income
trending_up-60M USD
-
Net Income
verified-61M USD
-
EPS
paid-0.61$
-
Revenue
$22.7M
MISS
$23.8M
$22.7M
$23.8M
$22.7M
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-
Net Income
$-60.6M
MISS
$-47.9M
$-60.6M
$-47.9M
$-60.6M
Estimate (Forecast)Actual (Actual)
FY2026 Q1 YoY
- $-
Surprise History
ActualEstimate
FY2025BEAT